160 related articles for article (PubMed ID: 22336752)
1. Heterogeneity among RIP-Tag2 insulinomas allows vascular endothelial growth factor-A independent tumor expansion as revealed by studies in Shb mutant mice: implications for tumor angiogenesis.
Åkerblom B; Zang G; Zhuang ZW; Calounova G; Simons M; Welsh M
Mol Oncol; 2012 Jun; 6(3):333-46. PubMed ID: 22336752
[TBL] [Abstract][Full Text] [Related]
2. Dysfunctional microvasculature as a consequence of shb gene inactivation causes impaired tumor growth.
Funa NS; Kriz V; Zang G; Calounova G; Akerblom B; Mares J; Larsson E; Sun Y; Betsholtz C; Welsh M
Cancer Res; 2009 Mar; 69(5):2141-8. PubMed ID: 19223532
[TBL] [Abstract][Full Text] [Related]
3. Vascular dysfunction and increased metastasis of B16F10 melanomas in Shb deficient mice as compared with their wild type counterparts.
Zang G; Gustafsson K; Jamalpour M; Hong J; Genové G; Welsh M
BMC Cancer; 2015 Apr; 15():234. PubMed ID: 25885274
[TBL] [Abstract][Full Text] [Related]
4. Aberrant association between vascular endothelial growth factor receptor-2 and VE-cadherin in response to vascular endothelial growth factor-a in Shb-deficient lung endothelial cells.
Zang G; Christoffersson G; Tian G; Harun-Or-Rashid M; Vågesjö E; Phillipson M; Barg S; Tengholm A; Welsh M
Cell Signal; 2013 Jan; 25(1):85-92. PubMed ID: 23000345
[TBL] [Abstract][Full Text] [Related]
5. Shb promotes blood vessel formation in embryoid bodies by augmenting vascular endothelial growth factor receptor-2 and platelet-derived growth factor receptor-beta signaling.
Rolny C; Lu L; Agren N; Nilsson I; Roe C; Webb GC; Welsh M
Exp Cell Res; 2005 Aug; 308(2):381-93. PubMed ID: 15919073
[TBL] [Abstract][Full Text] [Related]
6. Temporal Dynamics of VEGFA-Induced VEGFR2/FAK Co-Localization Depend on SHB.
Pietilä I; Van Mourik D; Tamelander A; Kriz V; Claesson-Welsh L; Tengholm A; Welsh M
Cells; 2019 Dec; 8(12):. PubMed ID: 31847469
[TBL] [Abstract][Full Text] [Related]
7. Shb gene knockdown increases the susceptibility of SVR endothelial tumor cells to apoptotic stimuli in vitro and in vivo.
Funa NS; Reddy K; Bhandarkar S; Kurenova EV; Yang L; Cance WG; Welsh M; Arbiser JL
J Invest Dermatol; 2008 Mar; 128(3):710-6. PubMed ID: 17914455
[TBL] [Abstract][Full Text] [Related]
8. Vascular adaptation to a dysfunctional endothelium as a consequence of Shb deficiency.
Christoffersson G; Zang G; Zhuang ZW; Vågesjö E; Simons M; Phillipson M; Welsh M
Angiogenesis; 2012 Sep; 15(3):469-80. PubMed ID: 22562363
[TBL] [Abstract][Full Text] [Related]
9. The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration.
Holmqvist K; Cross MJ; Rolny C; Hägerkvist R; Rahimi N; Matsumoto T; Claesson-Welsh L; Welsh M
J Biol Chem; 2004 May; 279(21):22267-75. PubMed ID: 15026417
[TBL] [Abstract][Full Text] [Related]
10. Loss of Serglycin Promotes Primary Tumor Growth and Vessel Functionality in the RIP1-Tag2 Mouse Model for Spontaneous Insulinoma Formation.
Hamilton A; Basic V; Andersson S; Abrink M; Ringvall M
PLoS One; 2015; 10(5):e0126688. PubMed ID: 25978773
[TBL] [Abstract][Full Text] [Related]
11. Mouse Breast Carcinoma Monocytic/Macrophagic Myeloid-Derived Suppressor Cell Infiltration as a Consequence of Endothelial Dysfunction in
He Q; Jamalpour M; Bergquist E; Anderson RL; Gustafsson K; Welsh M
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768912
[TBL] [Abstract][Full Text] [Related]
12. Shb deficiency in endothelium but not in leucocytes is responsible for impaired vascular performance during hindlimb ischaemia.
Nikpour M; Gustafsson K; Vågesjö E; Seignez C; Giraud A; Phillipson M; Welsh M
Acta Physiol (Oxf); 2015 Jun; 214(2):200-9. PubMed ID: 25561022
[TBL] [Abstract][Full Text] [Related]
13. Differential inhibition of tumor angiogenesis by tie2 and vascular endothelial growth factor receptor-2 dominant-negative receptor mutants.
Stratmann A; Acker T; Burger AM; Amann K; Risau W; Plate KH
Int J Cancer; 2001 Feb; 91(3):273-82. PubMed ID: 11169947
[TBL] [Abstract][Full Text] [Related]
14. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
15. Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma.
Patterson DM; Gao D; Trahan DN; Johnson BA; Ludwig A; Barbieri E; Chen Z; Diaz-Miron J; Vassilev L; Shohet JM; Kim ES
Angiogenesis; 2011 Sep; 14(3):255-66. PubMed ID: 21484514
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor receptor-1 (VEGFR-1) signaling enhances angiogenesis in a surgical sponge model.
Park K; Amano H; Ito Y; Kashiwagi S; Yamazaki Y; Takeda A; Shibuya M; Kitasato H; Majima M
Biomed Pharmacother; 2016 Mar; 78():140-149. PubMed ID: 26898435
[TBL] [Abstract][Full Text] [Related]
17. Impaired glucose homeostasis in Shb-/- mice.
Akerblom B; Barg S; Calounova G; Mokhtari D; Jansson L; Welsh M
J Endocrinol; 2009 Nov; 203(2):271-9. PubMed ID: 19696098
[TBL] [Abstract][Full Text] [Related]
18. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
Xiong J; Yang Q; Li J; Zhou S
Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
[TBL] [Abstract][Full Text] [Related]
19. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels.
Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G
J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432
[TBL] [Abstract][Full Text] [Related]
20. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
